Acurx Pharmaceuticals, Inc. (ACXP) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Acurex Pharmaceuticals first quarter 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I'd now like to turn the call over to your host, Mr. Rob Shawa, Chief Financial Officer. Please go ahead, sir. Thank you, Melissa. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the first quarter of 2026, which is available on our website at accorexpharma.com. Joining me today is Dave Lucci, President and CEO of Accorex, who will start by providing a corporate update and outlook. Following that, I'll provide some highlights of the financial results from the first quarter ended March 31, and then turn the call over to Dave for his closing remarks. As a reminder, during today's call, we'll be making certain forward-looking statements, which are based on current information, assumptions, estimates, and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Investors should consider these risks and other information described in our filings with the Securities and Exchange Commission, including our quarterly report on Form 10Q, which we filed yesterday, Monday, May 11, 2026. You are questioned not to place undue reliance on these forward-looking statements and after access claims any obligation to update such statements at any time in the future. This confere...